ANAPLASTIC LARGE CELL LYMPHOMA
Clinical trials for ANAPLASTIC LARGE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC LARGE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:29 UTC
-
Vitamin d boosts cancer survival in new mayo clinic trial
Disease control OngoingThis study looks at whether giving vitamin D to cancer patients who are low in it can help them live longer without their disease getting worse. About 565 adults with certain lymphomas or leukemia will either get vitamin D or no extra vitamin D. The goal is to see if vitamin D re…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug combo targets tough T-Cell lymphoma
Disease control TerminatedThis early-stage study tests whether combining two existing drugs, azacitidine and abatacept, can shrink tumors in people with T-cell lymphoma that has come back or not responded to prior therapy. About 20 adults will receive the drugs in 28-day cycles for up to 13 cycles. The go…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Engineered donor cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new type of CAR T-cell therapy made from donor cells (WU-CART-007) for people with CD7-positive blood cancers, including acute myeloid leukemia and T-cell lymphoma that have not responded to standard treatments. The therapy is designed to target and…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 19, 2026 11:47 UTC